INTRODUCTION Dermal fillers offer a nonsurgical approach for reducing facial rhytides and restoring facial volume. From 2000 to 2011, there were more than 13 new FDA-approved injectable fillers.1 In 2013,…

INTRODUCTION Onychomycosis is a progressive fungal infection of the nail bed, matrix or plate; it leads to destruction and deformity of the toenails and (less frequently) fingernails. 1,2 It represents…

INTRODUCTIONFrequency of dosing of any pharmaceutical product depends on its half-life—the shorter the half-life, the more frequent the dosing. Although longer half-lives can impact safety and adverse effects, they may…

CASE REPORT A 62-year-old Caucasian man with a past medical history of Hailey-Hailey disease, basal cell carcinoma on right upper lip and right temporal, hyperlipidemia, and chronic obstructive pulmonary disease…

INTRODUCTIONAcne scars may result from damage to the skin during the healing of active acne. The two causes of acne scar formation can be categorized as either a result of…

CASE REPORT A 66-year-old female underwent full-face fractional laser treatment with a 2790nm device. Five days later she developed multiple erythematous papules, some with central pustules, in the treatment areas…

INTRODUCTION The University of Pittsburgh Residency Program in Dermatology is a core part of one of the largest dermatology departments in the nation with 15 faculty members and 6 diverse…

At UPMC we take pride in our psoriasis clinic, where residents learn to prescribe and manage patients on biologic and other systemic therapies for psoriasis from day one of residency.DisclosuresAUTHOR…

CASE REPORTClinical Presentation A 35 year-old Caucasian female presented to clinic for a skin cancer screening examination. She had chronic gastrointestinal problems including reflux, bloating, constipation, and diarrhea. She had…

A patient with a history of meningoencephalitis presents with white patches on his body as shown. During the patient encounter, you also note that the patient has trouble hearing you.…

Valeant Pharmaceuticals Announces FDA Approval of OnextonApremilast Approval Expanded to Include Plaque PsoriasisiCAD/Xoft System- New Axxent SPX ControllerPromius Pharma Launches PromisebNovartis Announces FDA Advisory Committee Unanimously Recommends Approval of AIN457…

PSORIASISA Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 17…